Back to top

Welcome to MS Australia


MS disease modifying therapy, Aubagio® (​teriflunomide), to be delisted on the 1st October 2021

Pharmaceutical company Sanofi have advised that their MS disease modifying therapy (DMT), Aubagio (generic name, teriflunomide), will be delisted from the Australian market from approximately the 1st October 2021, exact date pending.

This decision has been made as the market for teriflunomide production opened to other pharmaceutical companies in 2019, allowing them to produce their own versions of the MS DMT using the generic medication...
How Daniel Andrews and COVID taught me a new way of living with my disabilityWhen Melbourne eases out of hard lockdown this month, I'm going to be walking particularly slow. It won't be because I am being diligent with newly-acquired 'COVID-Normal' behaviours.It will be because every step I take is aided by a walking stick.At other times — on worse days — I won't walk at all. I may stay under the doona instead, unable to walk because of chronic pain, fatigue, spasms and more. Or I might stand...

Tweets by @MS_Australia

Support & Services

As the national peak body for Australians living with MS, we work closely with the state MS organisations to help you connect with the right support and services.


Support & Services